Nymox Pharmaceutical Corporation (NYMX)
Add to Watchlists Create an Alert
5.28
+0.05 +0.96%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Pro Data Export
Nymox Pharmaceutical Corporation Key Statistics
Currency in USD
Current Valuation
Dividends and Shares
| Shares Outstanding | 33.95M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | 93.36% |
| Profit Margin Quarterly | -356.4% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 0.4735 |
| Debt to Equity Ratio | |
| Free Cash Flow | -1.963M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 7.54% |
| Year to Date Stock Returns | -23.03% |
| 1 Year Stock Returns | -31.25% |
| 3 Year Stock Returns | 23.94% |
| 52 Week High | 8.528 |
| 52 Week Low | 4.20 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 3.418M |
| Cash from Investing TTM | -0.0034M |
| Cash from Operations TTM | -8.304M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 1.048M |
| Long Term Debt | 0.00 |
| Total Assets | 1.754M |
| Liabilities | 9.599M |
| Shareholders Equity | -7.845M |
| Book Value | -7.845M |
| Book Value Per Share | -0.2311 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
NYMX News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NYMX | 5.28 | +0.05 | +0.96% | 179.23M |
New watchlist
